So - way behind you all as usual. Just finished li

So - way behind you all as usual. Just finished listening to the R&R presentation. I'm trying hard, right now, to not get really, really hyperexcited. Leo has finally taken the reigns and showed ownership of the trial info. Though I've wanted him to share more - I understand his choice to save it up to make impact at this conference. Sounds like they just received p21 results - at the finish line of the presentation. And it's working. Omfh. (anyone here from Boston who knows what that means?). Everything I wanted to hear about how K is doing - I heard. And though it isn't stopping disease progression yet - IT DID SHRINK TUMORS - necessitating oncologists restaging several. There was stabilization with progression. Soon we WILL see stabilization with no disease progression. The writing is on the wall. It is working. On its own. It will be able to stand alone - as long as we get to maximize the dose - as well as be used in combo. That near global usage we've dreamt of is becoming a concrete goal based on the evidence Leo presented today. Well tolerated. Well cleared. Efficacious activity - even if scant - so significant at these small doses. Serum tumor marker reductions confirmed - even at these doses. P21 activation seen. Shit. I am stunned.